|
Name |
Methyl 2,4-dihydroxy-6-methylbenzoate
|
Molecular Formula | C9H10O4 | |
IUPAC Name* |
methyl 2,4-dihydroxy-6-methylbenzoate
|
|
SMILES |
CC1=CC(=CC(=C1C(=O)OC)O)O
|
|
InChI |
InChI=1S/C9H10O4/c1-5-3-6(10)4-7(11)8(5)9(12)13-2/h3-4,10-11H,1-2H3
|
|
InChIKey |
NCCWCZLEACWJIN-UHFFFAOYSA-N
|
|
Synonyms |
Methyl orsellinate; Methyl 2,4-dihydroxy-6-methylbenzoate; 3187-58-4; methylorsellinate; Benzoic acid, 2,4-dihydroxy-6-methyl-, methyl ester; orsellinic acid methyl ester; Methyl 2,4-dihydroxy-6-methyl benzoate; CHEMBL454431; Orsellinic acid monomethyl ester; CHEBI:67898; 2,4-Dihydroxy-6-methylbenzoic acid methyl ester; Methyl 4,6-dihydroxy-2-methylbenzoate; Methyl o-orsellinate; Orsellinic acid methyl; Spectrum2_001751; .beta.-Resorcylic acid, 6-methyl-, methyl ester; SPECTRUM210925; MLS000728678; SCHEMBL370816; Benzoic acid,2,4-dihydroxy-6-methyl-, methyl ester; SPBio_001882; Methyl 6-methyl-ss-resorcylate; DTXSID2062901; HMS2267N11; ZINC391406; BDBM50294528; CCG-39451; AKOS000349113; methyl 2,4-dihydroxy-6-methyl-benzoate; NCGC00095797-01; BS-25248; SMR000470886; BB 0218022; CS-0023752; SR-01000761473; SR-01000761473-2; BRD-K12202814-001-05-8; Q27136372
|
|
CAS | 3187-58-4 | |
PubChem CID | 76658 | |
ChEMBL ID | CHEMBL454431 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 182.17 | ALogp: | 2.0 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 13 | QED Weighted: | 0.648 |
Caco-2 Permeability: | -4.649 | MDCK Permeability: | 0.00001380 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.029 |
Human Intestinal Absorption (HIA): | 0.011 | 20% Bioavailability (F20%): | 0.148 |
30% Bioavailability (F30%): | 0.197 |
Blood-Brain-Barrier Penetration (BBB): | 0.249 | Plasma Protein Binding (PPB): | 88.49% |
Volume Distribution (VD): | 0.797 | Fu: | 13.92% |
CYP1A2-inhibitor: | 0.972 | CYP1A2-substrate: | 0.868 |
CYP2C19-inhibitor: | 0.233 | CYP2C19-substrate: | 0.086 |
CYP2C9-inhibitor: | 0.192 | CYP2C9-substrate: | 0.894 |
CYP2D6-inhibitor: | 0.491 | CYP2D6-substrate: | 0.514 |
CYP3A4-inhibitor: | 0.625 | CYP3A4-substrate: | 0.177 |
Clearance (CL): | 14.547 | Half-life (T1/2): | 0.886 |
hERG Blockers: | 0.023 | Human Hepatotoxicity (H-HT): | 0.054 |
Drug-inuced Liver Injury (DILI): | 0.513 | AMES Toxicity: | 0.148 |
Rat Oral Acute Toxicity: | 0.029 | Maximum Recommended Daily Dose: | 0.524 |
Skin Sensitization: | 0.548 | Carcinogencity: | 0.032 |
Eye Corrosion: | 0.275 | Eye Irritation: | 0.98 |
Respiratory Toxicity: | 0.501 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005900 | 0.690 | D0U0OT | 0.321 | ||||
ENC000674 | 0.667 | D07EXH | 0.289 | ||||
ENC004205 | 0.640 | D0Y6KO | 0.270 | ||||
ENC004206 | 0.582 | D07MGA | 0.267 | ||||
ENC003332 | 0.580 | D01WJL | 0.260 | ||||
ENC005228 | 0.580 | D0C4YC | 0.260 | ||||
ENC002928 | 0.580 | D0BA6T | 0.259 | ||||
ENC002155 | 0.556 | D0Y7PG | 0.257 | ||||
ENC002944 | 0.542 | D0E9CD | 0.255 | ||||
ENC002653 | 0.536 | D0V9EN | 0.255 |